Document is current
Any future updates will be listed below
-
Authors
Barcellos-Hoff, Mary Helen https://orcid.org/0000-0002-5994-9558
Yom, Sue S. https://orcid.org/0000-0002-0779-7476
- License Information
-
More Information
Article History
Accepted: 1 April 2025
First Online: 19 May 2025
Competing interests
: M.H.B.-H. reports grants and non-financial support from Roche/Genentech; personal fees and non-financial support from Innovation Pathways, Inc.; consulting fees from Scholar Rock and Vericyte; non-financial support from Bicara during the conduct of the study; spoke at a meeting organized by for-profit Hanson-Wade in 2022 and 2023; has a patent pending for PCT/US2021/037078; and is a co-inventor on a patent pending (18/009,885) and a provisional patent (18/602,978) related to the βAlt signature owned by University of California, San Francisco (UCSF). S.S.Y. reports research support from Bristol-Myers Squibb, Merck, EMD Serono, Biomimetix and Nanobiotix.
